Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Deregulation of HER2 Downstream Signaling in Breast Cancer Cells by a Cocktail of Anti-HER2 scFvs, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, July 2013, Cognizant Communication Corporation,
DOI: 10.3727/096504013x13657689382734.
You can read the full text:
Contributors
The following have contributed to this page
